These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35434847)

  • 61. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The neuropathology of progressive supranuclear palsy.
    Lantos PL
    J Neural Transm Suppl; 1994; 42():137-52. PubMed ID: 7964683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progressive supranuclear palsy: pathology and genetics.
    Dickson DW; Rademakers R; Hutton ML
    Brain Pathol; 2007 Jan; 17(1):74-82. PubMed ID: 17493041
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei.
    Arima K; Murayama S; Oyanagi S; Akashi T; Inose T
    Acta Neuropathol; 1992; 84(2):128-34. PubMed ID: 1381857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy.
    Hanihara T; Amano N; Takahashi T; Nagatomo H; Yagashita S
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):319-26. PubMed ID: 7494600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The reappraisal study of the ultrastructure of Alzheimer's neurofibrillary tangles in three cases of progressive supranuclear palsy].
    Amano N; Iwabuchi K; Yokoi S; Yagishita S; Itoh Y; Saitoh A; Nagatomo H; Matsushita M
    No To Shinkei; 1989 Jan; 41(1):35-44. PubMed ID: 2655673
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Familial progressive supranuclear palsy.
    Gazeley S; Maguire JA
    Clin Neuropathol; 1996; 15(4):215-20. PubMed ID: 8836606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy.
    Iwasaki Y; Yoshida M; Hattori M; Goto A; Aiba I; Hashizume Y; Sobue G
    Acta Neuropathol; 2004 Nov; 108(5):399-405. PubMed ID: 15365723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies.
    DeRosier F; Hibbs C; Alessi K; Padda I; Rodriguez J; Pradeep S; Parmar MS
    Dis Mon; 2024 Aug; 70(8):101753. PubMed ID: 38908985
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Why are patients with progressive nonfluent aphasia nonfluent?
    Gunawardena D; Ash S; McMillan C; Avants B; Gee J; Grossman M
    Neurology; 2010 Aug; 75(7):588-94. PubMed ID: 20713947
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.
    Kida E; Barcikowska M; Niemczewska M
    Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.